Supernus Pharmaceuticals, Inc.

SUPN Nasdaq SEC CIK 1356576

Follow Supernus Pharmaceuticals Weekly email: filings, results, news

News

1 story filed under Supernus Pharmaceuticals

Markets 48 d ago also on INDV

NOV2

Q1 2026 results

Monday · estimated from the filing cadence

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 1 story clustered from the RSS aggregator